You searched for "studies"
Prevalence of acute anterior uveitis in diabetic patients attending diabetic eye disease clinics
The authors share their investigation at Manchester Royal Eye Hospital into the association between diabetes and AAU. The global prevalence of diabetes mellitus (DM) is rapidly rising from an estimated 9.3% in 2019 to 10.2% by 2030 [1]. The link...
Association of dry eye symptoms in patients with dyslipidaemia and statin use
1 August 2019
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
Meibomian gland dysfunction, dyslipidaemia, hypercholesterolaemia, lipid, statin
This retrospective analysis of the Blue Mountains Eye Study III cohort (Caucasian Australians residing west of Sydney n=1680; mean age >74 years, range 60-97) analysed the association between dyslipidaemia, use of oral statins and symptoms of dry disease (DED) among...
FMLM Conference 2024
26 March 2024
by Somain Verma, Ophthalmology Registrar (ST2), Northampton General Hospital. Clinical leadership is more important than ever. With an ever-increasingly burdened health system, we must assure that appropriate resources and systems are in place to maintain an effective and efficient health...
Importing iron to the retina
1 October 2017
| Graham Wallace
|
EYE - Vitreo-Retinal
In the retina, iron is particularly critical for the visual phototransduction cascade. In the retinal pigment epithelium (RPE), RPE65 activity leads to 11-cis-retinaldehyde, the photosensitive component of rhodopsin production and iron containing enzymes are necessary for disc replacement in photoreceptor...
Eye Surgeons of the Future
5 August 2022
Who and where are the eye surgeons of the year 2040? Chien Wong reports from a London school's Careers Fair.
Fingolimod: ocular adverse effects
1 October 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
Glaucoma UK’s campaign raises awareness of glaucoma through people’s unique glaucoma stories
Glaucoma UK is marking Glaucoma Awareness Week 2023, which will run from 26 June to 2 July 2023.Does a gut-eye axis exist?
1 October 2019
| Simerdip Kaur
|
EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Does a gut-eye axis exist? Over a decade ago, the Human Microbiome Project was launched by...
Exploiting nature’s randomised trials of eye disease
1 December 2022
| Skanda Rajasundaram, Dalia Abdulhussein, Christopher Bentley (Prof), Shafi Balal, Minak Bhalla
|
EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - Orbit
Confounding and reverse causation in observational ophthalmic epidemiology Traditional observational studies are inherently limited in establishing a causal effect of an exposure on an outcome of interest. One fundamental limitation is confounding, whereby causation is incorrectly attributed to a third...
RTP801 as a neuroprotective and axon regenerative treatment
1 April 2016
| Wai Siene Ng
|
EYE - Neuro-ophthalmology
This paper describes the neuroprotective and axon regenerative effects of siRTP801, which is a translatable small-interfering RNA (siRNA) targeting mTOR negative regulator; RTP801, through in-vivo and in-vitro models. In-vivo studies involved an optic nerve crush rat model with intravitreal injections...
Outcomes of cataract surgery in patients with uveitis
This is a systematic, evidence-based literature review and meta-analysis, looking at the visual outcomes (vision 20/40 or better) of cataract surgery in uveitic eyes. The authors searched MEDLINE, EMBASE, CINHAL and CENTRAL, including English language and human studies only. They...
